Trial intelligence / Profile preview

Pomalidomide in advanced chronic GVHD

NCT00770757Phase 2Completed

Sponsor
Washington University School of Medicine
Start
Feb 2009
Primary completion
Oct 2010
Modality
Molecular Glues
Countries
1
01

Overview

A Phase 2 trial of pomalidomide in chronic graft-versus-host disease (cGVHD), sponsored by Washington University School of Medicine. Started Feb 2009; status: completed.

02

Drugs

pomalidomide
03

Conditions

chronic graft-versus-host disease (cGVHD)

Beyond the preview

Go deeper on NCT00770757.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00770757.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call